Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-27 @ 11:08 PM
Study NCT ID:
NCT01158534
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2010-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-06
First Submit QC Date:
None
Study First Post Date:
2010-07-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-26
Results First Submit QC Date:
None
Results First Post Date:
2012-07-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-02
Last Update Post Date:
2012-08-07
Last Update Post Date Type:
ESTIMATED